Forschungsstrasse, Switzerland

Giulia Valpreda

This inventor holds 1 USPTO granted patent. Top assignees: ETH Zurich, Paul Scherrer Institut. Active years: 2026.


% Patents Active = 100.0

Average Co-Inventor Count = 5.0

ph-index = 1


Company Filing History:


Years Active: 2026

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Giulia Valpreda: Innovator in Tumor and Fibrosis Diagnosis

Introduction

Giulia Valpreda is a prominent inventor based in Forschungsstrasse, Switzerland. She has made significant contributions to the field of biomedical research, particularly in the diagnosis and therapy of tumors and fibrosis. Her innovative work has led to the development of valuable patents that enhance medical understanding and treatment options.

Latest Patents

Giulia Valpreda holds a patent titled "Conjugated Fibronectin-Binding Peptides for Use in Tumor or Fibrosis Diagnosis and Therapy." This patent represents her commitment to advancing medical science and improving patient outcomes. She has successfully secured 1 patent that showcases her expertise and dedication to innovation.

Career Highlights

Throughout her career, Giulia has worked with esteemed institutions such as ETH Zurich and the Paul Scherrer Institute. These experiences have allowed her to collaborate with leading experts in her field and contribute to groundbreaking research. Her work has been instrumental in bridging the gap between scientific discovery and practical application in medicine.

Collaborations

Giulia Valpreda has collaborated with notable colleagues, including Mamta Chabria and Viola Vogel. These partnerships have fostered a dynamic exchange of ideas and have been crucial in advancing their shared research goals.

Conclusion

Giulia Valpreda is a remarkable inventor whose work in tumor and fibrosis diagnosis is paving the way for future advancements in medical science. Her contributions are invaluable, and her innovative spirit continues to inspire others in the field.

Profile summary based on public USPTO records.
Please report any incorrect information to [email protected]
Loading…